News

VEON Transitions Trading to Nasdaq: A Strategic Move Forward

VEON Transitions Trading to Nasdaq: A Strategic Move Forward

VEON Announces Euronext Amsterdam Delisting

VEON Ltd., a global digital operator, has embarked on a significant milestone by starting the process to delist its common shares from Euronext Amsterdam. This news comes as part of the Company’s strategy to consolidate trading on the Nasdaq Capital Market in New York. Such a move is aimed at optimizing the trading environment for investors and enhancing liquidity.

Change in Trading Strategy

The delisting from Euronext Amsterdam is a well-thought-out decision backed by the approval from Euronext. VEON's last trading day on this platform will occur soon, allowing the company to focus exclusively on its Nasdaq listings. By transitioning fully to Nasdaq, VEON aims to promote a broader reach among investors with the ticker symbol VEON, ensuring that its American depositary shares can be traded more efficiently.

CEO's Perspective on the Move

Kaan Terzioglu, the CEO of VEON, expressed optimism about the transition, stating, "Our decision to consolidate our trading on Nasdaq aligns with our long-term strategy and the best interests of our investors." He emphasized that this consolidation will significantly strengthen VEON's liquidity and make regulatory reporting more straightforward for the Company.

Support for Shareholders

In light of the transition, VEON is committed to providing convenience and fairness for its shareholders. Before the last trading day, shareholders who do not currently hold a multiple of 25 Common Shares will have the opportunitiy to buy or sell shares to achieve this. This adjustment is crucial since each American depositary share (ADS) corresponds to 25 shares, ensuring a smooth transition.

Depository Solutions Offered

VEON is also facilitating the process for shareholders by allowing them to deposit shares with The Bank of New York Mellon. For every deposit made before the last trading date, the Company will waive AD issuance fees, supporting shareholders in navigating through the transition seamlessly.

Future Prospects and Commitment

Shareholders holding ADSs who are not also in possession of Common Shares listed on Euronext Amsterdam are reminded that no additional action is required from them. As VEON focuses on its primary trading platform on Nasdaq, the Company's commitment to creating value and enhancing accessibility remains steadfast.

About VEON's Operations

As a leader in digital operations, VEON currently reaches nearly 160 million customers across six countries. The Company is dedicated to transforming lives through innovative technology-driven services that not only empower individuals but also promote substantial economic growth. VEON's presence on Nasdaq, paired with its growing business initiatives, positions it favorably within the competitive telecommunications landscape.

Company Contact Information

VEON remains accessible to investors for further inquiries regarding this transition. Interested parties can reach out to:

Hande Asik, Group Director of Strategy and Communication, via email at pr@veon.com

Faisal Ghori, Group Director of Investor Relations, at ir@veon.com

Frequently Asked Questions

Why is VEON delisting from Euronext Amsterdam?

VEON is consolidating its trading operations to Nasdaq for enhanced liquidity and streamlined processes.

What does this mean for VEON shareholders?

Shareholders will need to align their holdings to multiples of 25 Common Shares for effective trading representation on Nasdaq.

Is there any action required for ADS holders?

No action is needed from ADS holders who do not hold shares on Euronext Amsterdam.

When will the delisting be effective?

The delisting will be effective after the last trading day on Euronext, September 22.

How can shareholders get more information?

Shareholders can access detailed information on VEON's official website and from investor relations contacts.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

Sprott Focus Trust Reports Quarterly Distribution and Insights

Updated Category News Views 195

Sprott Focus Trust Announces Quarterly Share Distribution In an uplifting update for investors, Sprott Focus Trust, Inc. (Nasdaq: FUND) has just declared a quarterly distribution of $0.1274 per share on its Common Stock. This distribution offers shareholders a choice between receiving payment in additional shares or cash. Set for disbursement on September 29, 2025,...

Continue Reading
Personal Injury Lawsuits: What You Need to Know Before Filing

Updated Category Personal Finance Views 1165

If you have been injured due to someone else's negligence or careless actions, you may be considering filing a personal injury lawsuit. Consulting a personal injury claim lawyer can help you understand your rights and the complexities involved in pursuing compensation. Personal injury lawsuits can be an effective way to recover damages for medical bills, lost wages, pain...

Continue Reading
Honeywell and Qualcomm Join Forces to Advance AI in Energy Sector

Updated Category News Views 188

Collaborating to Enhance AI Solutions in Energy Honeywell (NASDAQ: HON) and Qualcomm (NASDAQ: QCOM) Technologies, Inc. are making headlines with their groundbreaking collaboration aimed at revolutionizing artificial intelligence (AI) solutions within the energy sector. This partnership is a significant step towards enhancing Honeywell's automation offerings by seamlessly...

Continue Reading
Celebrating Diversity: The Best Gift for Foodies This Season

Updated Category News Views 106

Celebrating the Best Gift for Foodies Packed with Purpose (PwP), a Certified Woman-Owned and B Corp gifting company, has made headlines with its Black-Owned Spotlight Gift Basket, recently awarded as the Best Gift for Foodies. Understanding the Award Recognition This prestigious recognition comes from the USA Today 10Best Readers' Choice Awards, where a dedicated panel of...

Continue Reading
Coloplast A/S Updates Organic Growth and EBIT Margin Guidance

Updated Category News Views 620

Coloplast A/S Adjusts Financial Guidance for FY 2024/25 Coloplast A/S has revised its financial expectations for FY 2024/25, particularly in terms of organic growth and EBIT margin before special items. The anticipated organic growth has been adjusted to approximately 7%, down from the previous expectation of 8-9%. Additionally, the EBIT margin is now projected to be in...

Continue Reading